NCR1 and neoplasm: Tumor-infiltrating NKp46+ NKp44+ LTi-like ILC3s are endowed with ability to release several types of pro-inflammatory cytokines and chemokines, and their increased numbers correlated with intra-tumor TLS and predict favorable clinical outcome (185).